Literature DB >> 17291229

Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan.

H Kobayashi1, K Sumimoto, N Moniwa, M Imai, K Takakura, T Kuromaki, E Morioka, K Arisawa, T Terao.   

Abstract

Although some studies have indicated that endometriosis may increase the risk of developing ovarian cancer, there are no data from epidemiologic studies in Japan. We prospectively analyzed all cases of ovarian endometrioma enrolled in the prefecture-wide Shizuoka Cohort Study on Endometriosis and Ovarian Cancer Programme, which was initiated in 1985. To evaluate the risk of ovarian cancer by time periods subsequent to ovarian endometrioma diagnosis, a cohort of 6,398 women with a clinically documented ovarian endometrioma in Shizuoka between 1985 and 1995 was identified from the Shizuoka Cancer Registry (SCR), with follow-up through 2002. Ovarian cancer incidence among cohort members was ascertained by linkage to the SCR using a unique person-identification number. Standardized incidence ratios (SIR) and their 95% confidence intervals (CI) were computed by a use of prefecture-wide rates of ovarian cancer, adjusted for age and calendar year. During follow-up of up to 17 years of the ovarian endometrioma cohort, 46 incident ovarian cancers were identified, yielding that the ovarian cancer risk was elevated significantly among patients with ovarian endometrioma (SIR = 8.95, 95% CI = 4.12-15.3). The SIR did not increase with increasing follow-up duration. The risk increased with increasing age at ovarian endometrioma diagnosis, with a SIR equal to 13.2 (95% CI = 6.90-20.9) in women above 50 years of age. Our findings for the first time support the hypothesis that ovarian endometrioma increases the subsequent risk of developing ovarian cancer in Shizuoka, Japan.

Entities:  

Mesh:

Year:  2007        PMID: 17291229     DOI: 10.1111/j.1525-1438.2006.00754.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  73 in total

Review 1.  Potential scenarios leading to ovarian cancer arising from endometriosis.

Authors:  Hiroshi Kobayashi
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

2.  Comparison of redox parameters in ovarian endometrioma and its malignant transformation.

Authors:  Yoshikatsu Fujimoto; Shogo Imanaka; Yuki Yamada; Kenji Ogawa; Fuminori Ito; Naoki Kawahara; Chiharu Yoshimoto; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

3.  Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.

Authors:  Koji Matsuo; James C Cripe; Katherine C Kurnit; Michiko Kaneda; Audrey S Garneau; Gretchen E Glaser; Aaron Nizam; Rachel M Schillinger; Michelle L Kuznicki; Akira Yabuno; Shiori Yanai; Denise M Garofalo; Jiro Suzuki; Jessica D St Laurent; Ting-Tai Yen; Annie Y Liu; Masako Shida; Mamoru Kakuda; Tetsuro Oishi; Shin Nishio; Jenna Z Marcus; Sosuke Adachi; Tetsuji Kurokawa; Malcolm S Ross; Max P Horowitz; Marian S Johnson; Min K Kim; Alexander Melamed; Karime K Machado; Kosuke Yoshihara; Yoshio Yoshida; Takayuki Enomoto; Kimio Ushijima; Shinya Satoh; Yutaka Ueda; Mikio Mikami; Bobbie J Rimel; Rebecca L Stone; Whitfield B Growdon; Aikou Okamoto; Saketh R Guntupalli; Kosei Hasegawa; Mian M K Shahzad; Dwight D Im; Marina Frimer; Bobbie S Gostout; Frederick R Ueland; Shoji Nagao; Pamela T Soliman; Premal H Thaker; Jason D Wright; Lynda D Roman
Journal:  Gynecol Oncol       Date:  2019-08-16       Impact factor: 5.482

4.  A case of ovarian mucinous adenocarcinoma in a premenarcheal girl.

Authors:  Yoko Matsushita; Yoshihito Yokoyama; Ryousuke Taniguchi; Kazuhiro Abe; Jun Watanabe; Hideki Mizunuma
Journal:  Int J Clin Oncol       Date:  2011-10-22       Impact factor: 3.402

5.  Ovarian cancer in endometriosis.

Authors:  Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

6.  Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase isozymes in human ovarian surface epithelium and epithelial ovarian carcinoma.

Authors:  Ken-ichi Motohara; Hironori Tashiro; Yumiko Taura; Takashi Ohba; Hidetaka Katabuchi
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

7.  Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.

Authors:  Erina Suzuki; Sabine Kajita; Hiroyuki Takahashi; Toshihide Matsumoto; Tomoko Tsuruta; Makoto Saegusa
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

Review 8.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

9.  The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review).

Authors:  Hiroshi Shigetomi; Akira Oonogi; Taihei Tsunemi; Yasuhito Tanase; Yoshihiko Yamada; Hirotaka Kajihara; Yoriko Yoshizawa; Naoto Furukawa; Shoji Haruta; Shozo Yoshida; Toshiyuki Sado; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

10.  Endometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, Canada.

Authors:  Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-19       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.